REVEAL Registry Risk Score 2.0 for Pulmonary Arterial Hypertension (PAH)
Predicts survival in patients with pulmonary arterial hypertension.
IMPORTANT
This score was updated to reflect new literature published in 2019 with subsequent validation in 2020. New and/or revised variables include hospitalizations in the last 6 months and eGFR/renal insufficiency. Other previously existing variables were also studied and modified as supported in literature. Please see references listed in Evidence for further details.
When to Use
Associated PAH-portopulmonary hypertension
+3Familial PAH
+2Associated PAH-connective tissue disease
+1Other
0No
0Yes
+1No
0Yes
+2I
-1II
0III
+1IV
+2≥110 mmHg
0<110 mmHg
+1≤96 bpm
0>96 bpm
+1No
0Yes
+1≥440 m
-2320 to <440 m
-1165 to <320 m
0<165 m
+1<50 pg/mL
-250 to <200 pg/mL
0200 to <800 pg/mL
+1≥800 pg/mL
+2No
0Yes
+1≥40%
0<40%
+1No
0Yes
+1Yes
-1No
0Result:
Please fill out required fields.